MedWatch

ALK gains millions from webshop – may reach the size of the firm's core market

The allergy company ALK doesn't just get its money from allergy treatments, because millions of kroner are flowing in from online sales of consumer products such as inhalers and nasal sprays. The company's consumer care division may reach the size of ALK's core market, according to the CEO.

ALK CEO Carsten Hellmann. | Photo: Gregers Tycho/Ritzau/Ritzau Scanpix

Inhalers, nasal sprays, nose filters and home allergy kits.

The allergy firm ALK earns millions of kroner selling consumer products to people with allergies, and within a few years, this business area might become just as big as, if not bigger than the company's core market, injection and tablet-based vaccines, says ALK CEO Carsten Hellmann.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs